C. Sagné

发表

An Extended Proteome Map of the Lysosomal Membrane Reveals Novel Potential Transporters*

J. Garin, A. Chapel, M. Jadot, 2013, Molecular & Cellular Proteomics.

Successful Prediction of Substrate-binding Pocket in SLC17 Transporter Sialin*

F. Acher, H. Bertrand, R. Brossmer, 2012, The Journal of Biological Chemistry.

Functional characterization of wild‐type and mutant human sialin

C. Sagné, B. Gasnier, P. Morin, 2004, The EMBO journal.

Molecular pharmacology of the vesicular monoamine transporter.

J. Henry, C. Sagné, B. Gasnier, 1998, Advances in pharmacology.

Expression and regulation of the bovine vesicular monoamine transporter gene

J. Henry, E. Krejci, J. Gagnon, 1993, FEBS letters.

Heptahelical protein PQLC2 is a lysosomal cationic amino acid exporter underlying the action of cysteamine in cystinosis therapy

B. André, A. Chabli, B. Chadefaux-Vekemans, 2012, Proceedings of the National Academy of Sciences.

Expression and lysosomal targeting of CLN7, a major facilitator superfamily transporter associated with variant late-infantile neuronal ceroid lipofuscinosis.

S. El Mestikawy, M. Darmon, A. Jalanko, 2010, Human molecular genetics.

Noncovalent and covalent labeling of vesicular monoamine transporter with tetrabenazine and ketanserin derivatives; purification of photolabeled protein.

J. Henry, C. Sagné, B. Gasnier, 1998, Methods in enzymology.

Molecular physiology and pathophysiology of lysosomal membrane transporters

C. Sagné, B. Gasnier, 2008, Journal of Inherited Metabolic Disease.

Lysosomal amino acid transporter LYAAT‐1 in the rat central nervous system: An in situ hybridization and immunohistochemical study

B. Giros, P. Rostaing, A. Triller, 2003, The Journal of comparative neurology.

SNAT7 is the primary lysosomal glutamine exporter required for extracellular protein-dependent growth of cancer cells

M. Jadot, Marielle Boonen, C. Sagné, 2017, Proceedings of the National Academy of Sciences.

Identification of a putative lysosomal cobalamin exporter altered in the cblF defect of vitamin B12 metabolism

M. Baumgartner, T. Suormala, G. Nürnberg, 2009, Nature Genetics.

Molecular pathogenesis of sialic acid storage diseases: insight gained from four missense mutations and a putative polymorphism of human sialin

R. Ruivo, C. Sagné, B. Gasnier, 2008, Biology of the cell.

SDS-resistant aggregation of membrane proteins: application to the purification of the vesicular monoamine transporter.

J. Henry, C. Sagné, B. Gasnier, 1996, The Biochemical journal.

Small-Molecule 3D Ligand for RNA Recognition: Tuning Selectivity through Scaffold Hopping.

C. Sagné, Erica Benedetti, L. Micouin, 2022, ACS chemical biology.

The vesiicular monoamine transporter: from chromaffin granule to brain

J. Henry, C. Bedet, C. Sagné, 1998, Neurochemistry International.

Cloning of a functional vesicular GABA and glycine transporter by screening of genome databases

B. Giros, S. El Mestikawy, J. Henry, 1997, FEBS letters.

Mechanism of proton/substrate coupling in the heptahelical lysosomal transporter cystinosin

G. Bellenchi, R. Ruivo, C. Sagné, 2012, Proceedings of the National Academy of Sciences.

Identification and characterization of a lysosomal transporter for small neutral amino acids

B. Giros, S. El Mestikawy, M. Darmon, 2001, Proceedings of the National Academy of Sciences of the United States of America.

22 Lysosomal Membrane Transport in the Central Nervous System

C. Sagné, B. Gasnier, P. Morin, 2007 .

Enzyme replacement therapy: current challenges and drug delivery prospects via extracellular vesicles

F. Gazeau, I. Abasolo, C. Sagné, 2022, Rare Disease and Orphan Drugs Journal.

Biochemistry and molecular biology of the vesicular monoamine transporter from chromaffin granules.

J. Henry, V. Blanchard, E. Krejci, 1994, The Journal of experimental biology.

Molecular and cellular basis of lysosomal transmembrane protein dysfunction.

R. Ruivo, C. Sagné, B. Gasnier, 2009, Biochimica et biophysica acta.

Clinical or ATPase domain mutations in ABCD4 disrupt the interaction between the vitamin B12-trafficking proteins ABCD4 and LMBD1

M. Baumgartner, T. Suormala, D. S. Froese, 2017, The Journal of Biological Chemistry.

Neurotransmitter transporters in the central nervous system.

M. Hamon, S. El Mestikawy, C. Sagné, 1999, Pharmacological reviews.

Severe Serotonin Depletion after Conditional Deletion of the Vesicular Monoamine Transporter 2 Gene in Serotonin Neurons: Neural and Behavioral Consequences

P. Gaspar, L. Lanfumey, M. Martres, 2011, Neuropsychopharmacology.

Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter

Bertrand Bloch, Bruno Giros, M. Caron, 1999, The European journal of neuroscience.

A Na(+)/Cl(-)-dependent transporter for catecholamines, identified as a norepinephrine transporter, is expressed in the brain of the teleost fish medaka (Oryzias latipes).

B. Giros, P. Vernier, M. Kapsimali, 2001, Molecular pharmacology.

The photoactivatable inhibitor 7-azido-8-iodoketanserin labels the N terminus of the vesicular monoamine transporter from bovine chromaffin granules.

J. Vandekerckhove, J. Henry, C. Sagné, 1997, Biochemistry.

Clinical or ATPase domain mutations in ABCD4 disrupt the interaction between the vitamin B12-trafficking proteins ABCD4 and LMBD1

T. Suormala, D. S. Froese, P. Burda, 2017, The Journal of Biological Chemistry.